Normal 0 false false false MicrosoftInternetExplorer4 Several Indianapolis businesses are taking steps to protect against the spread of swine flu as the number of confirmed cases in the United States continues to rise. The U.S. Centers for Disease Control and Prevention yesterday reported 403 confirmed cases across 36 states – 124 more than were […]
Several Indianapolis businesses are taking steps to protect against the spread of swine flu as the number of confirmed cases in the United States continues to rise. The U.S. Centers for Disease Control and Prevention yesterday reported 403 confirmed cases across 36 states – 124 more than were confirmed the day before. Worldwide, the number […]
The struggling stock market took its toll on Lilly Endowment in 2008, dropping the value of its assets by 26 percent, from $7.7 billion to $5.7 billion, it announced today. The Indianapolis-based endowment’s value hit its lowest level in more than 10 years. The most recent peak was $15.5 billion in 2000. The drop means […]
The struggling stock market took its toll on Lilly Endowment in 2008, dropping the value of its assets by 26 percent, from $7.7 billion to $5.7 billion, it announced today. The Indianapolis-based endowment’s value hit its lowest level in more than 10 years. The most recent peak was $15.5 billion in 2000. The drop means […]
A prediction by a military historian in a recent issue of Foreign Policy has something for everyone, including
people interested in companies right here in Indiana.
Writing in a special section about the future, Martin van Creveld notes that…
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year,
Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
HEALTH CARE Pharma sets sail to China Drug companies-including Indianapolis-based Eli Lilly and Co.-are looking to ramp up sales internationally as the U.S. market contracts for the first time in 50 years. Sales of pharmaceuticals will fall 1 percent to 2 percent in the United States this year, according to a revised forecast from Connecticut-based […]
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year, Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch […]
While military contractors scramble to protect big projects from Defense Secretary Robert Gates’ budgetary ax, Indianapolis
engine-maker Rolls-Royce is sitting pretty.
Analyst: Expect prasugrel OK by May Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors April 21. He added that Wall […]
While military contractors scramble to protect big projects from Defense Secretary Robert Gates’ budgetary ax, Indianapolis engine-maker Rolls-Royce is sitting pretty. Rolls-Royce, which employs 4,300 in Indianapolis, is developing a key component for the Marine Corps’ version of the F-35 Joint Strike Fighter, potentially a big winner under a sweeping overhaul of priorities Gates unveiled […]
A federal judge in Indianapolis blocked today’s planned launch of a generic version of Evista, an osteoporosis and breast cancer drug made by Indianapolis-based Eli Lilly and Co. Sarah Evans Barker granted Lilly a preliminary injunction against Israel-based Teva Pharmaceuticals Industries Ltd. In March, Teva said it would wait until April 23 to launch its […]
Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors on Tuesday. He added that Wall Street expects prasugrel to receive full approval, despite being dogged […]
Indianapolis-based wireless-device distributor Brightpoint Inc. has joined the Fortune 500 for the first time, coming in 496th with $4.6 billion in 2008 revenue, according to the annual list of the nation’s largest companies released yesterday. Other Indiana companies to make the list: WellPoint Inc. (32), Eli Lilly and Co. (122), Cummins Inc. (181), NiSource Inc. […]
Eli Lilly and Co. saw only a slight bump in its share price this morning after reporting first quarter profit that exceeded analysts’ expectations by 21 percent. The Indianapolis-based drugmaker said part of that increase was caused by the rapid rise of the value of the U.S. dollar against foreign currencies. The benefit isn’t likely […]
Eli Lilly and Co. would buy San Diego-based biotech company Amylin Pharmaceuticals Inc. if corporate raider Carl Icahn gets his way. Icahn, a major investor in Amylin, is pushing for an immediate sale of the company to Indianapolis-based Lilly, according to a letter written by Amylin’s lead independent director, James N. Wilson. Amylin and Lilly […]
Eli Lilly and Co.’s profit soared above analysts’ expectations in the three months ended March 31. The Indianapolis-based drugmaker reported earnings per share of $1.20 this morning, well above the 99 cents Wall Street analysts had predicted, according to a survey by Thomson Financial. Lilly said first-quarter profit was $1.3 billion, up 24 percent from […]
IndyHub, the city’s young professionals network, will launch a new Web site, circlingthecity.com, to pique the interest of out-of-towners who are being recruited by local companies.
Indiana Gov. Mitch Daniels would make a remarkable president. Governor/ presidentâ??it’s the same game, just a different scale.
Indiana’s growing shipments to China averts a reversal in exports for the state, but core transportation equipment takes a
hit.
